Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „induce“
Suchtreffer
Begriffe & Kennungen
Biktarvy · 4.5 · Tenofovir alafenamide is not an inhibitor or inducer of CYP3A in vivo.
Eintrag öffnenBisphosphonat-assoziierte Kieferosteonekrose
Eintrag öffnenBleivergiftung, Nervensystem
Eintrag öffnenBleivergiftung, Nervensystem, beim Erwachsenen
Eintrag öffnenBleivergiftung, Nervensystem, im Kindesalter
Eintrag öffnenBondronat · 4.8 · Treatment of tumour induced hypercalcaemia is most frequently associated with a rise in body temperature. Less
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Sun · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Sun · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · Caution is warranted if mild CYP3A inducers are used concomitantly with bosutinib.
Eintrag öffnenBosulif · 4.8 · Two cases consistent with drug-induced liver injury (defined as concurrent elevations in ALT or AST ≥ 3 × ULN
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBraftovi · 4.5 · CYP3A4 inducers Co-administration of encorafenib with a strong CYP3A4 inducer was not assessed in a clinical s
Eintrag öffnenBrilique · 4.5 · 51 CYP3A inducers may decrease exposure and efficacy of ticagrelor, therefore, their concomitant use with tica
Eintrag öffnenBrilique · 4.5 · CYP3A inducers Co-administration of rifampicin with ticagrelor decreased ticagrelor Cmax and AUC by 73% and 86
Eintrag öffnenBrilique · 4.5 · CYP3A inducers Co-administration of rifampicin with ticagrelor decreased ticagrelor Cmax and AUC by 73% and 86
Eintrag öffnen